← All indications
Microscopic Polyangiitis
A primary systemic vasculitis of small- and some medium-sized vessels. It is characterized by a tropism for kidneys and lungs, positive association with anti-neutrophil cytoplasmic antibodies (ANCA), and a paucity of immunoglobulin deposits in vessel walls.
Drugs by status
Phase 4 trials (8)
Phase 3 trials (2)
Phase 2 trials (5)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (19)
- Human Genome Sciences
- GlaxoSmithKline
- National Institute of Allergy and Infectious Diseases (NIAID)
- University of Pennsylvania
- Johns Hopkins University
- Lund University
- University of Groningen
- University of Leicester
- University of Birmingham
- Mayo Clinic
- University of Copenhagen
- University of Freiburg
- Institut mutualiste, Paris, France
- French Vasculitis Study Group
- Fundació ACE
- Immune Tolerance Network
- University of Helsinki
- Assistance Publique - Hôpitaux de Paris
- Versus Arthritis
Organization Involved with Phase 2 Indications (4)
Organization Involved with Other Experimental Indications (1)